The present study was designed to evaluate the efficacy of a sodium hyaluronate/chondroitin sulfate, preservative-free, ophthalmic solution (SH/CS-PF) in normalizing the parameters of the ocular surface, alleviating symptoms and in reducing the squamous metaplasia using the conjunctival impression cytology (CIC) in patients with mild-moderate dry eye disease (DED).